Results 121 to 130 of about 40,208 (154)

Efficacy and safety of tofacitinib treatment in Finnish patients with juvenile idiopathic arthritis: a real-life study. [PDF]

Arthritis Res Ther
Levälampi T, Rebane K, Mikola K, Kautiainen H, Aalto K.   +4 more
europepmc   +1 more source

Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery. [PDF]

World J Clin Pediatr
Yakovlev AA, Gaidar EV, Sorokina LS, Nikitina TN, Chikova IA, Kalashnikova OV, Kostik MM.   +6 more
europepmc   +1 more source

Ethnic Differences in Juvenile Idiopathic Arthritis in the Circumpolar Region. [PDF]

Children (Basel)
Boeskorova SG, Afonskaya MV, Argunova VM, Sleptsova PA, Leonteva LV, Nikiforova VV, Chikova IA, Yakovlev AA, Burtseva TE, Kostik MM.   +9 more
europepmc   +1 more source

Ultrasound to Assess the Temporomandibular Joint of Children With Juvenile Idiopathic Arthritis: A Systematic Review. [PDF]

Int J Dent
Chana J, Baghaei K, Fagundes NCF, Hareendranatan A, Jaremko JL, Twilt M, Almeida FT.   +6 more
europepmc   +1 more source

Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. [PDF]

Pharmaceuticals (Basel)
Alexeeva EI, Dvoryakovskaya TM, Nikishina IP, Zholobova ES, Matkava VG, Krekhova EA, Raupov RK, Bukhanova DV, Egorova AN, Grishin SA, Samsonov MY, Kostik MM.   +11 more
europepmc   +1 more source

The emerging role of clinimetrics in pediatric rheumatology. [PDF]

Pediatr Rheumatol Online J
Anton J, Ravelli A.
europepmc   +1 more source

The role of systemic immune-inflammation index in differentiation of juvenile idiopathic arthritis from reactive arthritis among Chinese children. [PDF]

Front Med (Lausanne)
Ren G, Wang X, Liu Z.
europepmc   +1 more source

The epidemiology and biologics treatment patterns of juvenile idiopathic arthritis in Taiwan- an 8-year follow-up. [PDF]

Front Immunol
Hu YC, Huang YL, Yiao SY, Lin MT, Lin FJ, Yang YH.   +5 more
europepmc   +1 more source

Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS). [PDF]

Rheumatol Ther
Lam E, Berezny K, Bishop CJ, Lomax KG, Liva SG, Brunner HI, Paller AS, Diaz LZ, Lee LW, Rubin C, Carrasco R, Imundo L, Majlessi A, Smith V, Zhang R, Leu JH, U-POPS Study Group.   +16 more
europepmc   +1 more source